On this page
⚠ Educational content only Not medical or genetic advice. Speak with a healthcare provider or genetic counsellor before acting on anything here.

CHRNE

cholinergic receptor nicotinic epsilon subunit

The CHRNE gene provides instructions for producing a key component of the acetylcholine receptor (AChR) protein, essential for nerve-to-muscle communication. CHRNE encodes the epsilon subunit of the acetylcholine receptor, which plays a critical role in signalling at the neuromuscular junction.

Chromosome 17p13.2 Autosomal recessive HGNC:1966 Tier C
CHRNE 17p13.2 p arm q arm 17

CHRNE is located on the short (p) arm of chromosome 17, at band 17p13.2. Arm ratio per GRCh38 - banding schematic.

Explore chromosome 17 in the library →

Available at Jeen Health

Clinical tests that include this

Overview

The CHRNE gene, also known as cholinergic receptor nicotinic epsilon subunit, is crucial for proper muscle function. It provides genetic instructions for one of the five subunits that form the acetylcholine receptor (AChR) protein, an ion channel vital for transmitting signals between nerves and muscles.

Dysfunction of the CHRNE gene can disrupt this communication, leading to conditions characterised by muscle weakness and fatigue, such as congenital myasthenic syndromes. Understanding CHRNE is important for diagnosing and managing these inherited neuromuscular disorders.

What the gene does

The CHRNE gene produces the epsilon (ε) subunit, which is an integral part of the adult-type acetylcholine receptor (AChR) protein. The AChR is a pentameric protein, meaning it is assembled from five subunits, and is located on the surface of skeletal muscle cells. These receptors are concentrated at the neuromuscular junction, the specialised synapse where nerve cells transmit signals to muscle cells to initiate movement.

Within the endoplasmic reticulum, the five subunits of the AChR protein assemble. The epsilon subunit specifically replaces the gamma subunit around the 33rd week of pregnancy, forming the mature adult AChR. Once assembled, the AChR protein is transported to the muscle cell surface. When acetylcholine, a neurotransmitter, binds to the AChR, it causes an ion channel to open, leading to muscle contraction. Proper functioning of the epsilon subunit is therefore essential for effective nerve-muscle signalling and normal voluntary movement.

Video: Genetics 101

Chromosome location

The CHRNE gene is located on chromosome 17, specifically at position 17p13.2. This region denotes the short (p) arm of chromosome 17, band 13.2. The gene directs the synthesis of a protein comprising 493 amino acids.

Protein structure

The CHRNE gene encodes the epsilon subunit of the acetylcholine receptor. Domain architecture has not been experimentally characterised in detail for this protein.

Key variants

Variants within the CHRNE gene can alter the structure or function of the epsilon subunit, leading to impaired acetylcholine receptor function. These genetic changes can affect the assembly, stability, or activity of the receptor, consequently disrupting nerve-to-muscle signal transmission. Such variants are typically inherited in an autosomal recessive pattern.

The table below shows the top 10 pathogenic or likely-pathogenic variants currently classified in ClinVar for CHRNE.
View all on ClinVar →

Sample of pathogenic variants

10 pathogenic / likely-pathogenic variants from ClinVar, ranked by review status (expert-panel-reviewed first). This is a sample; recurrent founder variants in a specific population may not appear here - see the full ClinVar listing via the link above.

Variant (HGVS) Protein change Classification Evidence Associated condition
c.1002_1008dup
Duplication
p.Ala337fs Pathogenic ★★☆☆ Congenital myasthenic syndrome
c.1016_1032+2dup
Duplication
- Pathogenic/Likely pathogenic ★★☆☆ Congenital myasthenic syndrome 4B
c.1116_1128del
Deletion
p.Ser373fs Pathogenic/Likely pathogenic ★★☆☆ Congenital myasthenic syndrome
c.1248_1266dup
Duplication
p.Cys423fs Pathogenic ★★☆☆ Congenital myasthenic syndrome 4A
c.1251_1266dup
Duplication
p.Cys423fs Pathogenic/Likely pathogenic ★★☆☆ Congenital myasthenic syndrome
c.1255G>T
single nucleotide variant
p.Glu419Ter Pathogenic ★★☆☆ Congenital myasthenic syndrome 4A
c.1258del
Deletion
p.Val420fs Pathogenic/Likely pathogenic ★★☆☆ Congenital myasthenic syndrome
c.1379G>A
single nucleotide variant
p.Trp460Ter Pathogenic/Likely pathogenic ★★☆☆ Congenital myasthenic syndrome 4A
c.1381_1390del
Deletion
p.Ala461fs Pathogenic/Likely pathogenic ★★☆☆ Congenital myasthenic syndrome 4B
c.1383_1393del
Deletion
p.Ala462fs Pathogenic/Likely pathogenic ★★☆☆ Congenital myasthenic syndrome 4A

Evidence stars indicate ClinVar review status. Individual variant interpretation should always be performed by a qualified clinical laboratory - many variants remain classified as Variants of Uncertain Significance (VUS) pending more research.

Associated conditions

Pathogenic variants in the CHRNE gene are primarily associated with congenital myasthenic syndromes. These are a group of rare inherited disorders characterised by muscle weakness and fatigue, often beginning in infancy or early childhood. The severity and presentation of symptoms can vary among affected individuals.

  • Congenital myasthenic syndromes
    Neurogenetics
    AR
    Dedicated page coming soon

Inheritance pattern

Conditions caused by pathogenic CHRNE variants typically follow autosomal recessive inheritance.

♀ Carrier parent 1 altered copy ♂ Carrier parent 1 altered copy Affected Carrier Carrier Unaffected Affected Carrier Unaffected Circles = females · Squares = males

When both parents are carriers, each child has a 25% chance of being affected, 50% of being a carrier, and 25% of being unaffected.

Carrier frequency by population How common is heterozygous CHRNE carrier status across ancestry groups?

UK clinical status

The CHRNE gene is recognised within the NHS Genomic Medicine Service. It is listed on several green-rated PanelApp panels, including those for Arthrogryposis (R83), Congenital myaesthenic syndrome (R80), and Foetal anomalies (R21), indicating strong evidence for its association with these conditions and its inclusion in routine clinical genetic testing for relevant patients.

Frequently asked questions

What is the CHRNE gene responsible for?

The CHRNE gene provides instructions for making the epsilon subunit, a key component of the adult-type acetylcholine receptor protein. This receptor is vital for transmitting signals from nerves to muscles, enabling movement.

What are congenital myasthenic syndromes?

Congenital myasthenic syndromes are a group of inherited conditions characterised by muscle weakness and easy fatigability. They result from impaired communication between nerves and muscles, often due to genetic changes in genes like CHRNE.

How are CHRNE-related conditions inherited?

Conditions caused by variants in the CHRNE gene are typically inherited in an autosomal recessive pattern. This means an individual must inherit two copies of the altered gene (one from each parent) to develop the condition.

Educational content. This page is not medical or genetic advice, is not individually reviewed by a clinician for each reader, and should not replace a consultation with a qualified healthcare professional or genetic counsellor. If you are considering genetic testing or acting on a test result, book a consultation.
Data sources Last updated 11 October 2026. Content compiled from HGNC · MedlinePlus Genetics · ClinGen · Genomics England PanelApp · NHS National Genomic Test Directory · ClinVar · UniProt · AlphaFold .